APO-Easy Genotyping kit
Jun 2025
356d
Firalis SA has submitted 1 FDA 510(k) premarket notifications since 2025, of which 0 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Neurologic Disease Risk Assessment Molecular Test . Use the specialty filter in the sidebar to narrow results.